Biodexa Pharmaceuticals PLC Unsponsored ADR BDRX
0.68
0.00
0.00%
as of 25 Sep
- Market cap
- $700.0K
- P/E
- 0.0×
Follow BDRX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | (4.70) | (1.67) | (12.26) | (14.51) | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
— | — | 0.34 | 0.14 | 0.60 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | 0.26 | 0.11 | 0.38 | 0.27 | 0.15 | 0.03 | 0.15 | 0.37 |
EV/FCF |
— | — | 0.26 | 0.10 | 0.37 | 0.26 | 0.14 | 0.02 | 0.14 | 0.34 |
Quick Ratio |
2.03 | 1.75 | 1.26 | 2.47 | 6.39 | 3.10 | 2.42 | 2.27 | 2.11 | 2.30 |
Current Ratio |
2.03 | 1.75 | 1.26 | 2.47 | 6.39 | 3.10 | 2.42 | 2.27 | 2.22 | 2.39 |
Net Debt/EBITDA |
1.00 | 0.11 | 0.71 | 0.26 | 1.41 | 0.33 | 0.48 | 0.11 | 0.44 | 0.59 |
Debt/Assets |
0.34% | 4.92% | 4.40% | 11.29% | 5.93% | 2.65% | 19.69% | 6.12% | 13.30% | 3.81% |
Debt/Equity |
0.01 | 0.09 | 0.10 | 0.20 | 0.07 | 0.04 | 0.31 | 0.07 | 0.19 | 0.05 |
Asset Turnover |
0.00 | 0.00 | 0.05 | 0.07 | 0.05 | 0.02 | 0.03 | 0.06 | 0.14 | 0.11 |
Operating CF/Net income |
0.88 | 2.14 | 0.96 | 0.92 | 1.10 | 0.42 | 0.64 | 0.89 | 0.81 | 0.65 |
Capex/Depreciation |
(3.56) | (3.05) | (0.92) | (0.12) | (0.69) | (0.05) | (0.25) | (0.15) | (0.58) | (0.31) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (65.58%) | (88.99%) | (181.00%) | (103.59%) | (65.29%) | (169.59%) | (54.15%) | (59.64%) | (38.82%) | (40.89%) | |
| (39.28%) | (45.76%) | (88.29%) | (77.02%) | (49.46%) | (109.46%) | (38.59%) | (44.22%) | (29.52%) | (31.27%) | |
ROIC |
(184.28%) | (77.90%) | 0.00% | (587.61%) | (376.70%) | 0.00% | (48.08%) | (46.64%) | (39.21%) | (63.14%) |
Return on Tangible Assets |
(99.67%) | (139.73%) | (348.38%) | (211.55%) | (49.31%) | (324.97%) | (98.64%) | (292.98%) | (126.00%) | (128.22%) |
Average Days of Receivables |
0.00 | 0.00 | 1,014.59 | 967.04 | 1,076.08 | 1,839.92 | 1,521.24 | 616.82 | 213.20 | 204.46 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 1,067.50% | 731.18% | 805.20% | 1,769.14% | 1,163.69% | 482.93% | 134.05% | 96.55% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 1,139.69% | 649.78% | 509.69% | 1,445.53% | 617.82% | 226.73% | 165.37% | 270.77% |
Intangible Assets out of Total Assets |
0.31 | 0.38 | 0.28 | 0.00 | 0.00 | 0.00 | 0.40 | 0.61 | 0.56 | 0.55 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 7.34% | 17.59% | 15.40% | (117.78%) | (5.04%) | (1.86%) | 6.84% | 2.93% |
Graham Net Nets |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | (0.08%) | 0.00% | 0.00% | 0.00% | (63.75%) | (19.16%) | (103.94%) | (47.93%) |
Free Cash Flow Yield |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 789.83 | 0.00 | 0.05 | 0.05 | 0.23 | 0.85 | 0.38 | 0.52 |
Operating CF per Share |
(67.21) | (1,582.66) | (14,151.50) | 0.00 | (0.51) | (1.39) | (2.26) | (5.87) | (0.65) | (0.98) |
Capex per Share |
(8.09) | (99.91) | (537.00) | 0.00 | (0.02) | (0.01) | (0.11) | (0.10) | (0.07) | (0.10) |
Free Cash Flow per Share |
(75.30) | (1,682.57) | (14,688.50) | 0.00 | (0.54) | (1.40) | (2.37) | (5.97) | (0.73) | (1.09) |
Cash per Share |
102.59 | 215.43 | 12,378.83 | 0.00 | 0.86 | 1.13 | 3.81 | 1.02 | 0.66 | 1.32 |
Shareholders Equity per Share |
137.10 | 1,074.21 | 9,698.33 | 0.00 | 0.89 | 1.01 | 6.81 | 7.39 | 1.74 | 3.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
137.10 | 1,074.21 | 9,698.33 | 0.00 | 0.89 | 1.01 | 6.81 | 7.39 | 1.74 | 3.44 |
Free Cash Flow |
(8.26) | (16.66) | (8.81) | (8.77) | (8.64) | (12.03) | (8.69) | (18.25) | (18.61) | (19.59) |
Working Capital |
8.33 | 4.83 | 1.82 | 3.45 | 13.64 | 8.07 | 10.30 | 4.20 | 13.17 | 17.56 |
Capital Expenditures |
(0.89) | (0.99) | (0.32) | (0.05) | (0.38) | (0.08) | (0.41) | (0.29) | (1.91) | (1.85) |
Net Current Asset Value |
7.48 | 3.01 | 1.45 | 2.88 | 12.79 | 7.93 | 3.06 | 2.80 | 5.20 | 15.37 |
EV/EBIT |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.68 | 0.06 | 0.48 | 0.19 | 0.47 | 0.11 | 0.20 | 0.20 |
Net Profit Margin |
0.00% | 0.00% | (1,858.11%) | (1,095.27%) | (944.64%) | (6,469.28%) | (1,496.34%) | (775.55%) | (211.42%) | (291.23%) |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.08 | 0.78 | 0.50 | 0.41 | 0.35 | 2.25 | 0.60 | 0.73 | 1.01 | 1.57 |
Cash ROIC |
(28.41%) | (117.42%) | (66.56%) | (118.98%) | (33.65%) | (67.77%) | (23.64%) | (75.21%) | (28.45%) | (24.21%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.26 | 0.37 | 0.35 | 0.15 | 0.22 | 0.51 | 1.78 | 1.72 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.08 |
Inventory Turnover |
— | — | — | — | — | — | — | 0.00 | 1.03 | 1.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,154.22 | 4,600.45 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | 0.00 | 370.93 | 447.08 |
Average Receivables |
7.14 | 5.22 | 1.80 | 2.32 | 2.28 | 2.90 | 3.98 | 5.05 | 5.49 | 5.45 |
Average Payables |
3.95 | 3.01 | 1.67 | 1.65 | 1.54 | 3.66 | 4.27 | 6.56 | 10.85 | 11.11 |
Average Inventory |
— | — | — | — | — | — | — | 0.83 | 1.16 | 0.90 |
Average Assets |
21.43 | 16.00 | 9.97 | 12.30 | 15.18 | 26.03 | 33.37 | 45.36 | 70.14 | 87.37 |
Average Common Equity |
12.84 | 8.23 | 4.87 | 9.14 | 11.50 | 16.80 | 23.78 | 33.64 | 53.33 | 66.83 |
Columns are period end dates